Wednesday , December 2 2020

The new influenza drug in Japan, which heals within 24 hours – News Now

(NEWS) .-Japanese doctors are already working on a drug that can kill the flu virus in one day, He said Friday the Japanese Ministry of Health.

According to the manufacturer, Shionogi & Co., Ltd., tablets I promise to kill flu for 24 hours and were approved Friday.

The test showed that Xofluza was likely to kill influenza viruses than any other treatment is available, including Tamiflu Roche AG, one of the best on the market.

The Food and Drug Administration (FDA for its abbreviation in English) has been approved medicine Xofluza manufacturer, in October last year.

The Wall Street Journal said, quick approval would mean that Shionogi & Co. may start selling Xofluza.

Only a few new products, including TamifluThey are there to treat people once they are infected.

Existing drugs allow the virus occupies cells and, instead, to work to prevent the virus from shoots and infect other cells. Xofluza works to prevent the flu virus to take over cells, CEO of Shionogi, said Isao Teshirogi.

Xofluza, which works differently than existing drugs against influenza, This requires a single dose.

Study in a patient with influenza in Japan and the United States, showed that Xofluza average time it took to remove the virus was 24 hours. Tamiflu took three times as much to achieve the same test result.

but the tablet may not be available in Japan until May because the national insurance company still set the price, said a company spokesman.

Of Shionogi, based in Osaka, plans to receive approval from the United States. UU. this year. Roche of Switzerland has purchased a license to sell Xofluza abroad, even in the United States. UU.

In addition, Johnson & Johnson and AstraZeneca PLC Some of the other companies testing new compounds for the treatment of influenza A, the most common strain of influenza.

But it may be several years before the results from the & # 39 are commercially available.

Shionogi said it is also working against drug strains of influenza B, and experts believe that this could be a breakthrough in the way the disease is treated.

Source link